Drugs.com - Pharma Industry News

Obinutuzumab Efficacious for Renal Response in Lupus Nephritis

WEDNESDAY, Feb. 26, 2025 -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone...

Feb 26, 2025 - 18:25
 0
Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
WEDNESDAY, Feb. 26, 2025 -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone...
Read More

Tags:

Previous Article

Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodi...

Next Article

Children With Obesity Have Increased Rates of Dermatologic Conditions

Related Posts

Better Mental Health Linked to Resilience in Older Wome...

Feb 9, 2025  0

Recommendations Updated for Fertility Preservation in Cancer

Recommendations Updated for Fertility Preservation in C...

Apr 10, 2025  0

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide...

Mar 12, 2025  0